家族性高胆固醇血症的护理模式：临床生物化学的关键作用。
A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.
作者信息
Watts Gerald F, Sullivan David R, van Bockxmeer Frank M, Poplawski Nicola, Hamilton-Craig Ian, Clifton Peter M, O'Brien Richard C, George Peter M, Burnett John R
机构信息
Lipid Disorders Clinic, Metabolic Research Centre and Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia;
出版信息
Clin Biochem Rev. 2012 Feb;33(1):25-31.
Abstract
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that causes marked elevation in plasma low-density lipoprotein (LDL) cholesterol concentrations and premature coronary heart disease. There are at least 45,000 people with FH in Australia and New Zealand, but most remain unrecognised and those diagnosed remain inadequately treated. To bridge this gap in coronary prevention the FH Australasia Network has developed a model of care for FH. An executive summary of the model of care is presented, with a commentary on its recommendations and the key role of the clinical biochemistry laboratory.
摘要
家族性高胆固醇血症（FH）是一种从出生就存在的常染色体显性遗传疾病，它会导致血浆低密度脂蛋白（LDL）胆固醇浓度显著升高，并引发早发性冠心病。在澳大利亚和新西兰，至少有45000人患有FH，但大多数人仍未被诊断出来，而那些已确诊的患者也未得到充分治疗。为了填补冠心病预防方面的这一空白，澳大拉西亚FH网络已经制定了一套FH护理模式。本文给出了该护理模式的执行摘要，并对其建议以及临床生物化学实验室的关键作用进行了评论。
相似文献
1
A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.
Clin Biochem Rev. 2012 Feb;33(1):25-31.
2
A new model of care for familial hypercholesterolaemia: what is the role of cardiology?
Heart Lung Circ. 2012 Sep;21(9):543-50. doi: 10.1016/j.hlc.2012.04.010. Epub 2012 May 25.
3
Familial hypercholesterolaemia: a model of care for Australasia.
Atheroscler Suppl. 2011 Oct;12(2):221-63. doi: 10.1016/j.atherosclerosissup.2011.06.001. Epub 2011 Sep 13.
4
Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?
Int J Clin Pharm. 2012 Aug;34(4):501-5. doi: 10.1007/s11096-012-9646-y. Epub 2012 May 24.
5
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Int J Cardiol. 2014 Feb 15;171(3):309-25. doi: 10.1016/j.ijcard.2013.11.025. Epub 2013 Nov 20.
6
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia.
Heart Lung Circ. 2021 Mar;30(3):324-349. doi: 10.1016/j.hlc.2020.09.943. Epub 2020 Dec 9.
7
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Eur J Prev Cardiol. 2015 Jul;22(7):849-54. doi: 10.1177/2047487314533218. Epub 2014 Apr 28.
8
Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application.
Heart Lung Circ. 2020 Apr;29(4):619-633. doi: 10.1016/j.hlc.2019.12.002. Epub 2019 Dec 24.
9
Low-density lipoprotein apheresis: an evidence-based analysis.
Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.
10
Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Atherosclerosis. 2015 Mar;239(1):93-100. doi: 10.1016/j.atherosclerosis.2014.12.036. Epub 2014 Dec 23.
引用本文的文献
1
"Uninsurable because of a genetic test": a qualitative study of consumer views about the use of genetic test results in Australian life insurance.
Eur J Hum Genet. 2024 Jul;32(7):827-836. doi: 10.1038/s41431-024-01602-1. Epub 2024 Apr 19.
2
Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands.
Genes (Basel). 2021 Jul 29;12(8):1168. doi: 10.3390/genes12081168.
3
Awareness of Familial Hypercholesterolemia Among Healthcare Providers Involved in the Management of Acute Coronary Syndrome in Victoria, Australia.
CJC Open. 2019 Jun 7;1(4):168-172. doi: 10.1016/j.cjco.2019.05.001. eCollection 2019 Jul.
4
The tertiary hospital laboratory; a novel avenue of opportunistic screening of familial hypercholesterolemia.
Int J Cardiol Heart Vasc. 2019 May 3;23:100354. doi: 10.1016/j.ijcha.2019.100354. eCollection 2019 Jun.
5
Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.
BMJ Open. 2017 Oct 22;7(10):e017539. doi: 10.1136/bmjopen-2017-017539.
6
Genetic insights into cardiometabolic risk factors.
Clin Biochem Rev. 2014 Feb;35(1):15-36.
本文引用的文献
1
Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus?
Atheroscler Suppl. 2011 Oct;12(2):217-20. doi: 10.1016/S1567-5688(11)00037-7.
2
Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.
Circulation. 2011 Nov 15;124(20):2202-7. doi: 10.1161/CIRCULATIONAHA.111.042523. Epub 2011 Oct 10.
3
Familial hypercholesterolaemia: a model of care for Australasia.
Atheroscler Suppl. 2011 Oct;12(2):221-63. doi: 10.1016/j.atherosclerosissup.2011.06.001. Epub 2011 Sep 13.
4
Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.
Atherosclerosis. 2011 Oct;218(2):272-80. doi: 10.1016/j.atherosclerosis.2011.06.016. Epub 2011 Jun 17.
5
The paradox of public health genomics: definition and diagnosis of familial hypercholesterolaemia in three European countries.
Scand J Public Health. 2011 Aug;39(6):634-9. doi: 10.1177/1403494811414241. Epub 2011 Jul 5.
6
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158. Epub 2011 Jun 28.
7
Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
J Clin Lipidol. 2011 Jun;5(3 Suppl):S18-29. doi: 10.1016/j.jacl.2011.03.451. Epub 2011 Apr 3.
8
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
J Clin Lipidol. 2011 May-Jun;5(3):133-140. doi: 10.1016/j.jacl.2011.03.001. Epub 2011 Mar 11.
9
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2010 Dec 21;122(25):2748-64. doi: 10.1161/CIR.0b013e3182051bab. Epub 2010 Nov 15.
10
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
Curr Opin Lipidol. 2010 Aug;21(4):366-71. doi: 10.1097/MOL.0b013e32833c14e2.
Zotero 插件